Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel.

Sharma P, López-Tarruella S, García-Saenz JA, Khan QJ, Gómez HL, Prat A, Moreno F, Jerez-Gilarranz Y, Barnadas A, Picornell AC, Monte-Millán MD, González-Rivera M, Massarrah T, Pelaez-Lorenzo B, Palomero MI, González Del Val R, Cortés J, Fuentes-Rivera H, Morales DB, Márquez-Rodas I, Perou CM, Lehn C, Wang YY, Klemp JR, Mammen JV, Wagner JL, Amin AL, O'Dea AP, Heldstab J, Jensen RA, Kimler BF, Godwin AK, Martín M.

Clin Cancer Res. 2018 Dec 1;24(23):5820-5829. doi: 10.1158/1078-0432.CCR-18-0585. Epub 2018 Jul 30.

PMID:
30061361
2.

Reducing Breast Cancer-Related Lymphedema (BCRL) Through Prospective Surveillance Monitoring Using Bioimpedance Spectroscopy (BIS) and Patient Directed Self-Interventions.

Kilgore LJ, Korentager SS, Hangge AN, Amin AL, Balanoff CR, Larson KE, Mitchell MP, Chen JG, Burgen E, Khan QJ, O'Dea AP, Nye L, Sharma P, Wagner JL.

Ann Surg Oncol. 2018 Oct;25(10):2948-2952. doi: 10.1245/s10434-018-6601-8. Epub 2018 Jul 9.

PMID:
29987599
3.

Cognitive functioning and quality of life following chemotherapy in pre- and peri-menopausal women with breast cancer.

Klemp JR, Myers JS, Fabian CJ, Kimler BF, Khan QJ, Sereika SM, Stanton AL.

Support Care Cancer. 2018 Feb;26(2):575-583. doi: 10.1007/s00520-017-3869-3. Epub 2017 Aug 28.

4.

Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial.

Khan QJ, Kimler BF, Reddy PS, Sharma P, Klemp JR, Nydegger JL, Yeh HW, Fabian CJ.

Breast Cancer Res Treat. 2017 Nov;166(2):491-500. doi: 10.1007/s10549-017-4429-8. Epub 2017 Aug 2.

PMID:
28770449
5.

A randomized adaptive phase II/III study of buparlisib, a pan-class I PI3K inhibitor, combined with paclitaxel for the treatment of HER2- advanced breast cancer (BELLE-4).

Martín M, Chan A, Dirix L, O'Shaughnessy J, Hegg R, Manikhas A, Shtivelband M, Krivorotko P, Batista López N, Campone M, Ruiz Borrego M, Khan QJ, Beck JT, Ramos Vázquez M, Urban P, Goteti S, Di Tomaso E, Massacesi C, Delaloge S.

Ann Oncol. 2017 Feb 1;28(2):313-320. doi: 10.1093/annonc/mdw562.

PMID:
27803006
6.

Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer.

Rugo HS, Olopade OI, DeMichele A, Yau C, van 't Veer LJ, Buxton MB, Hogarth M, Hylton NM, Paoloni M, Perlmutter J, Symmans WF, Yee D, Chien AJ, Wallace AM, Kaplan HG, Boughey JC, Haddad TC, Albain KS, Liu MC, Isaacs C, Khan QJ, Lang JE, Viscusi RK, Pusztai L, Moulder SL, Chui SY, Kemmer KA, Elias AD, Edmiston KK, Euhus DM, Haley BB, Nanda R, Northfelt DW, Tripathy D, Wood WC, Ewing C, Schwab R, Lyandres J, Davis SE, Hirst GL, Sanil A, Berry DA, Esserman LJ; I-SPY 2 Investigators.

N Engl J Med. 2016 Jul 7;375(1):23-34. doi: 10.1056/NEJMoa1513749.

7.

Adaptive Randomization of Neratinib in Early Breast Cancer.

Park JW, Liu MC, Yee D, Yau C, van 't Veer LJ, Symmans WF, Paoloni M, Perlmutter J, Hylton NM, Hogarth M, DeMichele A, Buxton MB, Chien AJ, Wallace AM, Boughey JC, Haddad TC, Chui SY, Kemmer KA, Kaplan HG, Isaacs C, Nanda R, Tripathy D, Albain KS, Edmiston KK, Elias AD, Northfelt DW, Pusztai L, Moulder SL, Lang JE, Viscusi RK, Euhus DM, Haley BB, Khan QJ, Wood WC, Melisko M, Schwab R, Helsten T, Lyandres J, Davis SE, Hirst GL, Sanil A, Esserman LJ, Berry DA; I-SPY 2 Investigators.

N Engl J Med. 2016 Jul 7;375(1):11-22. doi: 10.1056/NEJMoa1513750.

8.

Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two Cohorts.

Sharma P, López-Tarruella S, García-Saenz JA, Ward C, Connor CS, Gómez HL, Prat A, Moreno F, Jerez-Gilarranz Y, Barnadas A, Picornell AC, Del Monte-Millán M, Gonzalez-Rivera M, Massarrah T, Pelaez-Lorenzo B, Palomero MI, González Del Val R, Cortes J, Fuentes Rivera H, Bretel Morales D, Márquez-Rodas I, Perou CM, Wagner JL, Mammen JM, McGinness MK, Klemp JR, Amin AL, Fabian CJ, Heldstab J, Godwin AK, Jensen RA, Kimler BF, Khan QJ, Martin M.

Clin Cancer Res. 2017 Feb 1;23(3):649-657. doi: 10.1158/1078-0432.CCR-16-0162. Epub 2016 Jun 14.

9.

Chaos control via feeding switching in an omnivory system.

Chattopadhyay J, Pal N, Samanta S, Venturino E, Khan QJ.

Biosystems. 2015 Dec;138:18-24. doi: 10.1016/j.biosystems.2015.10.006. Epub 2015 Oct 29.

PMID:
26521665
10.

A delayed eco-epidemiological system with infected prey and predator subject to the weak Allee effect.

Biswas S, Sasmal SK, Samanta S, Saifuddin M, Khan QJ, Chattopadhyay J.

Math Biosci. 2015 May;263:198-208. doi: 10.1016/j.mbs.2015.02.013. Epub 2015 Mar 5.

PMID:
25747414
11.

Impact of neoadjuvant chemotherapy on axillary nodal involvement in patients with clinically node negative triple negative breast cancer.

Connor CS, Kimler BF, Mammen JM, McGinness MK, Wagner JL, Alsop SM, Ward C, Fabian CJ, Khan QJ, Sharma P.

J Surg Oncol. 2015 Feb;111(2):198-202. doi: 10.1002/jso.23790. Epub 2014 Sep 29.

PMID:
25266871
12.

Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing.

Sharma P, Klemp JR, Kimler BF, Mahnken JD, Geier LJ, Khan QJ, Elia M, Connor CS, McGinness MK, Mammen JM, Wagner JL, Ward C, Ranallo L, Knight CJ, Stecklein SR, Jensen RA, Fabian CJ, Godwin AK.

Breast Cancer Res Treat. 2014 Jun;145(3):707-14. doi: 10.1007/s10549-014-2980-0. Epub 2014 May 7.

13.

Clinicopathological characteristics of triple-negative invasive mammary carcinomas in African-American versus Caucasian women.

Tawfik O, Davis K, Kimler BF, Davis MK, Hull S, Fan F, Khan QJ, O'Dea AP, Thomas P.

Ann Clin Lab Sci. 2010 Fall;40(4):315-23.

PMID:
20947804
14.

Musculoskeletal adverse events associated with adjuvant aromatase inhibitors.

Khan QJ, O'Dea AP, Sharma P.

J Oncol. 2010;2010. pii: 654348. doi: 10.1155/2010/654348. Epub 2010 Aug 24.

15.

Reduction in Ki-67 in benign breast tissue of high-risk women with the lignan secoisolariciresinol diglycoside.

Fabian CJ, Kimler BF, Zalles CM, Klemp JR, Petroff BK, Khan QJ, Sharma P, Setchell KD, Zhao X, Phillips TA, Metheny T, Hughes JR, Yeh HW, Johnson KA.

Cancer Prev Res (Phila). 2010 Oct;3(10):1342-50. doi: 10.1158/1940-6207.CAPR-10-0022. Epub 2010 Aug 19.

16.

How I treat vitamin d deficiency.

Khan QJ, Fabian CJ.

J Oncol Pract. 2010 Mar;6(2):97-101. doi: 10.1200/JOP.091087.

17.

The relationship between vitamin D and breast cancer incidence and natural history.

Khan QJ, Kimler BF, Fabian CJ.

Curr Oncol Rep. 2010 Mar;12(2):136-42. doi: 10.1007/s11912-010-0081-8. Review.

PMID:
20425599
18.

Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer.

Khan QJ, Reddy PS, Kimler BF, Sharma P, Baxa SE, O'Dea AP, Klemp JR, Fabian CJ.

Breast Cancer Res Treat. 2010 Jan;119(1):111-8. doi: 10.1007/s10549-009-0495-x. Epub 2009 Aug 5.

20.

Reduction in proliferation with six months of letrozole in women on hormone replacement therapy.

Fabian CJ, Kimler BF, Zalles CM, Khan QJ, Mayo MS, Phillips TA, Simonsen M, Metheny T, Petroff BK.

Breast Cancer Res Treat. 2007 Nov;106(1):75-84. Epub 2007 Jan 13.

PMID:
17221152
21.

Effect of naproxen on the pharmacokinetic parameters of rifampicin.

Ansari MT, Loothar BA, Khan QJ.

Pak J Pharm Sci. 2001 Jan;14(1):13-7.

PMID:
16414847
22.

Pharmacokinetic study about interaction of Naproxen and Isoniazid.

Ansari MT, Loothar BA, Khan QJ.

Pak J Pharm Sci. 1999 Jan;12(1):27-32.

PMID:
16414824
23.

Ki-67 expression in benign breast ductal cells obtained by random periareolar fine needle aspiration.

Bhandare D, Khan SA, Fabian CJ, Khan QJ.

Cancer Epidemiol Biomarkers Prev. 2005 Sep;14(9):2278; author reply 2278-9. No abstract available.

24.

Ki-67 expression in benign breast ductal cells obtained by random periareolar fine needle aspiration.

Khan QJ, Kimler BF, Clark J, Metheny T, Zalles CM, Fabian CJ.

Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):786-9.

25.

Analysis of a predator-prey system with predator switching.

Khan QJ, Balakrishnan E, Wake GC.

Bull Math Biol. 2004 Jan;66(1):109-23.

PMID:
14670532
26.

A study of prey-predator relations for mammals.

Khan QJ, Ghaleb AF.

J Theor Biol. 2003 Jul 21;223(2):171-8.

PMID:
12814600
27.

The stability of internal equilibria in predator-prey models with breeding suppression.

Ruxton GD, Khan QJ, Al-Lawatia M.

IMA J Math Appl Med Biol. 2002 Sep;19(3):207-19.

PMID:
12650335
28.

Hopf bifurcation in epidemic models with a time delay in vaccination.

Khan QJ, Greenhalgh D.

IMA J Math Appl Med Biol. 1999 Jun;16(2):113-42.

PMID:
10399309

Supplemental Content

Support Center